Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline.
J Clin Endocrinol Metab
; 108(9): 2336-2342, 2023 08 18.
Article
in En
| MEDLINE
| ID: mdl-36856782
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adrenal Cortex Neoplasms
/
Adrenocortical Carcinoma
/
Hypothyroidism
Type of study:
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2023
Document type:
Article
Affiliation country:
Canada